AlgaHealth was founded in 2017 and since then has demonstrated feasibility and developed three product prototypes: a dry powder, an oleoresin extracted without the presence of organic solvents, and an oleoresin extracted in ethanol. Each of the products is designed for a different market.
AlgaHealth operates an R&D laboratory and pilot production plant in Ein Shemer and is about to set up an industrial production plant.
AlgaHealth plans to start full-scale production and sales in 2022, after expanding its production capabilities to a full industrial scale, completing regulatory proceedings in major target markets and developing its marketing and sales infrastructure.
CEO with over thirty years of management experience. Prior to founding AlgaHealth Hagay served for eight years as CEO of Algatechnologies , which he turned from a losing enterprise into a world global in the microalgae industry, with an exit of dozens of millions of USD. He is a mentor and advisor to many companies in microalgae cultivation and research
Oran Ayalon, Ph.D
CTO with over twenty years of experience in biotech R&D and marketing management positions in, extensive experience with microalgae, including as VP for R&D of leading microalgae companies Algatechnologies and Algalo Industries. Oran holds a PhD in biology and chemistryfrom the Weizmann Institute of Science in Rehovot, Israel and an MBA from Bar-Ilan University.
A pilot plant started operation in Ein-Shemer
Three prototype products demonstrate feasibility.